Nurse Practitioner, Family · Milwaukee, WI
NPI
1457920407
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
9200 W Wisconsin Ave
Milwaukee, WI, 53226
Phone (414) 805-6550
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
585 services
Medicare patients, 2024
143
Average age 68
Drug cost, 2024
$1.3M
2,239 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olivia A Cassiday was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 81 times for 57 patients. In total Olivia A Cassiday billed 585 services in 10 codes, and Medicare paid $20K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 81 | 57 | $9.90 | $802 |
| 99214 Office E&M - Established | Facility | 76 | 59 | $53.93 | $4,099 |
| 83036 Blood Count | Office | 67 | 43 | $9.52 | $638 |
| 82962 Clinical Chemistry | Office | 62 | 42 | $3.16 | $196 |
| 99215 Office E&M - Established | Facility | 48 | 42 | $75.73 | $3,635 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 41 | 33 | $10.22 | $419 |
| 95251 Test - Miscellaneous | Facility | 41 | 33 | $20.97 | $860 |
| 99213 Office E&M - Established | Facility | 38 | 33 | $39.34 | $1,495 |
| 99214 Office E&M - Established | Office | 37 | 35 | $77.65 | $2,873 |
| 95251 Test - Miscellaneous | Office | 37 | 24 | $20.84 | $771 |
| 99215 Office E&M - Established | Office | 31 | 26 | $102.60 | $3,181 |
| 99213 Office E&M - Established | Office | 21 | 18 | $57.91 | $1,216 |
By year: 2022 $7,153 for 108 services; 2023 $13K for 180 services; 2024 $20K for 585 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 67 | 43 | $9.52 | $638 |
| 82962 Clinical Chemistry | 62 | 42 | $3.16 | $196 |
Medicare prescription drug claims, 2024
In 2024, the drug Olivia A Cassiday prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 308 prescriptions and refills. In total Olivia A Cassiday wrote 2,239 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 308 | 360 | 49 | $378K |
| Ozempic Semaglutide | 297 | 429 | 63 | $405K |
| Metformin Hcl Er Metformin Hcl | 218 | 562 | 81 | $2,066 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 135 | 279 | 49 | $15K |
| Jardiance Empagliflozin | 86 | 194 | 21 | $111K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 75 | 140 | 21 | $25K |
| Novolin 70-30 Flexpen Insulin Nph Hum/Reg Insulin Hm | 73 | 120 | 21 | $15K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 73 | 178 | 33 | $7,328 |
| Novolog Flexpen Insulin Aspart | 61 | 99 | 25 | $18K |
| Levothyroxine Sodium Generic | 59 | 127 | 16 | $487 |
| Trulicity Dulaglutide | 50 | 70 | 11 | $67K |
| Atorvastatin Calcium Generic | 47 | 135 | 19 | $355 |
| Topiramate Generic | 39 | 78 | 13 | $265 |
| Humalog Kwikpen U-100 Insulin Lispro | 36 | 73 | 17 | $14K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 34 | 79 | 13 | $3,453 |
Brand drugs: 1,441 claims; generic drugs: 560 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Olivia A Cassiday were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.